Drug Development healthcare technology Industry Leadership 
Digital Health Global
MARCH 2, 2023
Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.
Lloyd Price
NOVEMBER 21, 2023
By implementing these strategies, Palantir can effectively address public concerns, build trust, and gain acceptance for its role in delivering the NHS Federated Data Platform, ultimately contributing to improved patient care and healthcare outcomes in England. Palantir's products are used by a variety of industries, including healthcare.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
MAY 2, 2024
Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
Lloyd Price
MAY 6, 2024
Exec Summary: AI has revolutionised the weather industry by providing faster, more accurate, and personalised weather predictions. This has significant benefits for public safety, disaster preparedness, and various industries that rely on weather information. Visit www.nelsonadvisors.co.uk Subscribe Today!
Lloyd Price
FEBRUARY 18, 2024
Mergers and acquisitions: The promising future of GLP-1s led to several mergers and acquisitions within the healthtech industry. These deals aimed to consolidate market share, expand research capabilities, and accelerate product development, further stimulating investor interest.
Lloyd Price
FEBRUARY 2, 2024
Benefits for healthcare stakeholders: Streamlined patient onboarding: Verifiable credentials from SSI wallets can expedite patient registration and verification, reducing administrative burdens and improving wait times. Regulatory frameworks and industry-wide collaboration are key drivers.
Digital Health Global
JUNE 20, 2023
These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,
Expert insights. Personalized for you.
88 
Let's personalize your content